Functional Characterization of a Novel MYBPC3 Splice-Altering Variant Identified in a Chinese Patient with Hypertrophic Cardiomyopathy
Journal of Cardiovascular Development and Disease · 10.11.2026 · 13 (11) · 582
DOI: 10.3390/jcdd13110582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 10.11.2026. Verfasst von Hangyu Liu und 4 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Natural Science Foundation.
Abstract (Originalsprache)
Background
Hypertrophic cardiomyopathy (HCM) is a genetically heterogeneous myocardial disorder in which variants in MYBPC3 represent a major genetic cause, although the functional significance of newly identified splice-region variants often remains uncertain.
Methods
We investigated a previously unreported heterozygous MYBPC3 variant, NM_000256.3: c.2414-6_2421del, identified by whole-exome sequencing in a Chinese male patient with HCM and cardiac dysfunction. Adenoviral vectors expressing wild-type (Ad-WT) or mutant (Ad-MUT) MYBPC3 were used to establish cardiomyocyte models.
Results
Compared with Ad-WT cells, Ad-MUT cells showed increased ANP and BNP expression, enhanced ERK phosphorylation, and cytoskeletal alterations assessed by phalloidin staining, indicating a hypertrophic cellular response. Three region-specific RT-qPCR assays demonstrated reduced MYBPC3 transcript abundance in Ad-MUT cells, with a greater reduction in the exon 25–26-spanning amplicon, suggesting altered RNA processing involving the variant-adjacent region. Cycloheximide treatment increased the abundance of mutant-associated transcripts, supporting their degradation through nonsense-mediated mRNA decay.
Conclusions
MYBPC3 c.2414-6_2421del disrupts transcript processing and promotes nonsense-mediated mRNA decay (NMD)-associated transcript depletion, accompanied by cardiomyocyte hypertrophic remodeling. These findings provide functional evidence relevant to the interpretation of this previously unreported variant in HCM.
Förderung
- National Natural Science Foundation of China
- Jiangxi Provincial Natural Science Foundation
Zitieren
APA
Liu, H., Hua, J., Xiong, Q., Xiong, L., & Chen, Q. (2026). Functional Characterization of a Novel MYBPC3 Splice-Altering Variant Identified in a Chinese Patient with Hypertrophic Cardiomyopathy. Journal of Cardiovascular Development and Disease, 13(11), 582. https://doi.org/10.3390/jcdd13110582
Vancouver
Liu H, Hua J, Xiong Q, Xiong L, Chen Q. Functional Characterization of a Novel MYBPC3 Splice-Altering Variant Identified in a Chinese Patient with Hypertrophic Cardiomyopathy. Journal of Cardiovascular Development and Disease. 2026;13(11):582. doi:10.3390/jcdd13110582
BibTeX
@article{Liu2026,
author = {Liu, Hangyu and Hua, Juan and Xiong, Qinmei and Xiong, Liang and Chen, Qi},
title = {Functional Characterization of a Novel MYBPC3 Splice-Altering Variant Identified in a Chinese Patient with Hypertrophic Cardiomyopathy},
journal = {Journal of Cardiovascular Development and Disease},
year = {2026},
volume = {13},
number = {11},
pages = {582},
doi = {10.3390/jcdd13110582}
}
EUVIMED